Fulgent Genetics (FLGT) Retained Earnings (2015 - 2026)

Fulgent Genetics has disclosed Retained Earnings across 12 years of filings, most recently posting $4.5 million for Q1 2026.

• Retained Earnings for Q1 2026 came in at $4.5 million, down 99.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.5 million (down 99.22% YoY), and the FY2025 annual result was $530.0 million, down 10.25% from the prior year.
• Retained Earnings came in at $4.5 million for Q1 2026 at Fulgent Genetics, down from $530.0 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $823.1 million in Q2 2022 to a low of -$25.6 million in Q3 2022.
• The 5-year median for Retained Earnings is $9.2 million (2024), against an average of $291.2 million.
• Peak annual rise in Retained Earnings reached 310708.68% in 2022, while the deepest fall reached 2456.6% in 2022.
• Fulgent Genetics' Retained Earnings stood at -$20.9 million in 2022, then jumped by 105.76% to $1.2 million in 2023, then surged by 48901.41% to $590.5 million in 2024, then slipped by 10.25% to $530.0 million in 2025, then plunged by 99.14% to $4.5 million in 2026.
• The last three Retained Earnings figures came in at $4.5 million (Q1 2026), $530.0 million (Q4 2025), and $553.4 million (Q3 2025), per Business Quant data.